Skip to main content
Humana Inc (HUM)
Health Services Health Care
Stock AI

Humana Inc. Expands Value-Based Cardiology Care for Medicare Advantage Members

Last updated: March 03, 2026
Taurigo

Louisville, KY – March 3, 2026 – Humana Inc. (NYSE: HUM) has announced the launch of new partnerships aimed at enhancing cardiovascular health for eligible Medicare Advantage members. This initiative builds on the company's existing collaboration with CVAUSA’s Novocardia Care Solutions division and introduces new partnerships with Karoo Health, US Heart and Vascular, and Chamber Cardio. These strategic alliances are designed to provide comprehensive cardiac care, reinforcing Humana’s commitment to value-based healthcare.

1. Enhancing Cardiac Care Services

Humana’s latest partnerships are set to deliver a suite of advanced cardiac care services for its Individual and Group Medicare Advantage members. These services are tailored to improve quality of life and minimize hospital admissions for members managing heart conditions.

Key Features of the Initiative

The enhanced services will include:

  • Value-Based Care Teams: These teams focus on proactive, evidence-based care, helping members maintain better health and prevent complications, thus reducing unnecessary emergency visits.
  • 24/7 Hotline Access: Members will have round-the-clock access to a coordinated care team, simplifying the management of heart conditions through continuous support.
  • Remote Monitoring Tools: Localized teams will monitor vital indicators such as heart rate, rhythm, and blood pressure to proactively address potential issues before they escalate.
  • Integrated Team Support: Care management teams will work closely with participating cardiologists to create personalized care plans, ensuring that tests, medications, and dietary needs align with members' specific health requirements.

2. A Commitment to Improved Outcomes

Caraline Coats, Senior Vice President of Clinical Strategy at Humana, emphasized the importance of integrated and coordinated care. “Managing a heart condition can feel overwhelming. Our members need integrated, coordinated, evidence-based care that meets them where they are,” she stated. Humana’s commitment to expanding access to high-quality, whole-person care is expected to lead to better health outcomes for its members.

The company’s analysis indicates that value-based care not only enhances the quality of care but also improves adherence to evidence-based medicine, particularly for cardiac patients.

3. Geographic Availability of Services

The expanded cardiac care services will be accessible to Individual and Group Medicare Advantage members in various states, including:

  • CVAUSA's Novocardia Care Solutions: Available in Florida, Georgia, South Carolina, Illinois, North Carolina, and Iowa.
  • Karoo Health: Services offered in Arizona, Illinois, Alabama, Mississippi, and Louisiana.
  • Chamber Cardio: Available in Maryland, Georgia, South Carolina, North Carolina, Virginia, Washington, DC, and Texas.
  • US Heart and Vascular: Services provided in Alabama, Arizona, Louisiana, Texas, and Kansas.

Other providers may also be available within the Humana network, and participating providers may contract with other plan sponsors.

4. About Humana Inc.

Humana Inc. is a leading U.S. healthcare company dedicated to making healthcare easier for millions of individuals. Through its insurance services and CenterWell healthcare services, Humana strives to deliver the necessary care and support, ultimately improving the quality of life for people across various demographics, including those with Medicare and Medicaid, families, military personnel, and the broader community.

For more information about Humana’s offerings, interested parties can visit Humana.com and CenterWell.com.

This expansion of services not only reflects Humana’s ongoing commitment to enhancing healthcare access but also positions the company as a leader in the value-based care model, particularly in the realm of cardiology.

You may also be interested in:
Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.